Skip to main content
64°
Partly Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by NanoVibronix, Inc.
< Previous
1
2
Next >
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
September 27, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
September 06, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 30, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Cites Positive Results from Independent Testing of UroShield
August 30, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Responds to CMS’ Determination for PainShield
August 29, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
August 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
August 23, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard
June 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Issues Letter to Shareholders
May 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Issues Letter to Shareholders
April 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS)
March 28, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra
March 21, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury
March 14, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Regains Nasdaq Compliance
March 03, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix to Launch Rental Program for PainShield and UroShield
February 22, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Reverse Stock Split
February 08, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Provides Update on Expanding Access to PainShield
January 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
December 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Partnership with Peak Medical, Ltd.
December 13, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 01, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
November 28, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Interim Results of Clinical Study for UroShield
November 16, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Provides Business Update in Letter to Shareholders
November 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
October 19, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
September 23, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Sets Date for Annual Shareholder Meeting
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
September 02, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
NanoVibronix Provides Business Update in Letter to Shareholders
August 18, 2022
From
NanoVibronix, Inc.
Via
Business Wire
Tickers
NAOV
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.